Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Encorafenib 300 / Cetuximab 250, Colorectal Carcinoma, Cycle 2+

Protocol-ID: 1606 V1.0 (Mini), ENCO300/CETU250, colorect. Ca, C2+

Indication(s)

  • Colon Cancer; ICD-10 C18.0, C18.2, C18.3, C18.4, C18.5, C18.6, C18.7, C18.8, C19

Links

The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 07.08.2020